1. Home
  2. EDRY vs UBX Comparison

EDRY vs UBX Comparison

Compare EDRY & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDRY
  • UBX
  • Stock Information
  • Founded
  • EDRY 2018
  • UBX 2009
  • Country
  • EDRY Greece
  • UBX United States
  • Employees
  • EDRY N/A
  • UBX N/A
  • Industry
  • EDRY Marine Transportation
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDRY Consumer Discretionary
  • UBX Health Care
  • Exchange
  • EDRY Nasdaq
  • UBX Nasdaq
  • Market Cap
  • EDRY 31.7M
  • UBX 38.6M
  • IPO Year
  • EDRY N/A
  • UBX 2018
  • Fundamental
  • Price
  • EDRY $11.18
  • UBX $2.10
  • Analyst Decision
  • EDRY
  • UBX Strong Buy
  • Analyst Count
  • EDRY 0
  • UBX 2
  • Target Price
  • EDRY N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • EDRY 8.2K
  • UBX 364.5K
  • Earning Date
  • EDRY 02-18-2025
  • UBX 11-04-2024
  • Dividend Yield
  • EDRY N/A
  • UBX N/A
  • EPS Growth
  • EDRY N/A
  • UBX N/A
  • EPS
  • EDRY N/A
  • UBX N/A
  • Revenue
  • EDRY $65,085,280.00
  • UBX N/A
  • Revenue This Year
  • EDRY $34.61
  • UBX N/A
  • Revenue Next Year
  • EDRY $15.93
  • UBX $33.62
  • P/E Ratio
  • EDRY N/A
  • UBX N/A
  • Revenue Growth
  • EDRY 39.04
  • UBX N/A
  • 52 Week Low
  • EDRY $10.04
  • UBX $0.94
  • 52 Week High
  • EDRY $24.84
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • EDRY 42.93
  • UBX 62.50
  • Support Level
  • EDRY $10.40
  • UBX $2.05
  • Resistance Level
  • EDRY $11.72
  • UBX $2.42
  • Average True Range (ATR)
  • EDRY 0.49
  • UBX 0.31
  • MACD
  • EDRY 0.01
  • UBX -0.01
  • Stochastic Oscillator
  • EDRY 37.86
  • UBX 41.67

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: